KiOmed Pharma

medical devices

About

KiOmed Pharma is a Belgian biotechnology company that develops, manufactures, and distributes innovative medical devices using a unique, non-animal-derived chitosan chemistry. As a spinout from KitoZyme, the company focuses on addressing significant medical needs in areas such as osteoarthritis, skin aging, and ophthalmology. The company's proprietary technology platform, KiOmedine®, employs a biodegradable chitosan biopolymer to create effective therapeutic solutions. One of its key products is KioMedine(vs)one, a single-injection soft implant designed to alleviate pain and enhance mobility for patients with knee osteoarthritis. This product is available in Europe and is also being developed for the Chinese market through a licensing agreement with Hansoh Pharmaceutical Group. KiOmed Pharma is committed to biocompatibility and safety, ensuring its formulations are derived from non-animal sources. Headquartered in Herstal, Liège, Belgium, KiOmed Pharma is led by CEO Houtaï Choumane and employs a dedicated team. The company aims to improve patient outcomes through its innovative medical devices and has established strategic partnerships to expand its global reach.

Technologies

Outlook Microsoft Office 365 reCAPTCHA Varnish Apache WordPress.org Vimeo Mobile Friendly Remote

Keywords

rheumatology joint health dermatology regenerative medicine biosurgery animalfree chitosan medical devices implants biomaterials ultrapure chitosan rheumatology amp joint health medical devices amp implants medical equipment manufacturing medical equipment and supplies manufacturing oxidative stress protection clinical value biotech tissue protection medical devices biopolymer regulatory approval manufacturing b2b refractory osteoarthritis biotechnology pharmaceuticals cm-chitosan chitosan sustainable attributes eye drops healthcare dermal fillers

Location

4 Rue Haute Marexhe, Herstal, Walloon Region, Belgium, 4040

Related Companies

Companies in the same industry